文献速递自身免疫性与大疱性皮肤病药疹与重症皮肤不良反应

格列汀相关大疱性类天疱疮显示抗BP180和抗BP230体液反应的独特特征:一项多中心研究结果

Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study.
PubMed 文献 · J Am Acad Dermatol · 2022-03-01

该研究前瞻性纳入2013至2020年意大利9个皮肤科单位的74例格列汀相关大疱性类天疱疮患者,发现其常表现为非炎症表型,且对BP180和BP230的IgG、IgE和IgA体液反应频率和滴度较特发性大疱性类天疱疮患者降低,IgG反应靶向多个BP180表位而非仅非胶原区16A。

要点

  • 格列汀相关大疱性类天疱疮患者常表现为非炎症表型,循环和皮肤浸润嗜酸性粒细胞数量低。
  • 对BP180和BP230的IgG、IgE和IgA反应频率和滴度较特发性大疱性类天疱疮患者降低。
  • IgG反应靶向多个BP180表位,而非仅非胶原区16A。

核心结论

  • 格列汀相关大疱性类天疱疮患者显示抗BP180和抗BP230体液反应的独特特征,为诊断改进和了解大疱性类天疱疮发病机制奠定基础。

研究设计与样本

  • 前瞻性纳入2013至2020年意大利9个皮肤科单位的74例格列汀相关大疱性类天疱疮患者并进行临床和免疫学特征分析。

主要发现

  • 格列汀相关大疱性类天疱疮患者常发现非炎症表型,特征为循环和皮肤浸润嗜酸性粒细胞数量低。
  • 对BP180和BP230的IgG、IgE和IgA体液反应频率和滴度较特发性大疱性类天疱疮患者降低。
  • IgG反应靶向多个BP180表位而非仅非胶原区16A。

局限性

  • 研究的局限性在于对照组未仅由2型糖尿病合并大疱性类天疱疮的患者组成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recently, several case-control studies demonstrated an association between gliptins and bullous pemphigoid (BP) occurrence. However, data on the clinical and immunologic features of gliptin-associated bullous pemphigoid (GABP) are controversial. OBJECTIVE: This study aimed to clinically and immunologically characterize a large cohort of GABP patients to get an insight into the pathophysiology of this emerging drug-induced variant of BP. METHODS: Seventy-four GABP patients were prospectively enrolled and characterized from 9 different Italian dermatology units between 2013 and 2020. RESULTS: Our findings demonstrated the following in the GABP patients: (1) a noninflammatory phenotype, which is characterized by low amounts of circulating and skin-infiltrating eosinophils, is frequently found; (2) immunoglobulin (Ig)G, IgE, and IgA humoral responses to BP180 and BP230 antigens are reduced in frequency and titers compared with those in patients with idiopathic BP; (3) IgG reactivity targets multiple BP180 epitopes other than noncollagenous region 16A. LIMITATIONS: A limitation of the study is that the control group did not comprise only type 2 diabetes mellitus patients with BP. CONCLUSION: GABP patients show peculiar features of anti-BP180 and -BP230 humoral responses, laying the foundation for diagnostic improvements and getting novel insights into understanding the mechanism of BP onset.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Salemme A, Fania L, Scarabello A, et al. Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study. J Am Acad Dermatol. 2022. PMID: 35240229. doi:10.1016/j.jaad.2022.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。